Amanote Research

Amanote Research

    RegisterSign In

Impact of Introducing Costs/Qaly Threshold on Access to Oncology Medicines in Slovakia

Value in Health - United Kingdom
doi 10.1016/j.jval.2014.08.2387
Full Text
Open PDF
Abstract

Available in full text

Categories
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
Date

November 1, 2014

Authors
M. PsenkovaS. MackovicovaD. Tomek
Publisher

Elsevier BV


Related search

Impact of Global Policy Reforms on Equity in Access to Medicines in India

2016English

Impact of Electronic Access to Physician Notes on Oncology Patients: A Prospective Evaluation

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2018English

Pcn297 - Impact of Economic Sanctions on Access to Noncommunicable Diseases Medicines in the Islamic Republic of Iran

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Proposals on Faster NHS Access to New Medicines

Prescriber
Pharmacology
2017English

Access to Essential Medicines in National Constitutions

Bulletin of the World Health Organization
EnvironmentalPublic HealthOccupational Health
2010English

TheSocialMedwork: Providing Access to Overseas Medicines

Prescriber
Pharmacology
2019English

Access to Medicines—business as Usual?

The Lancet Global Health
Medicine
2019English

Reforming Canada's Access to Medicines Regime

CMAJ
Medicine
2007English

How the MDGs Gave Up on Measuring Access to Medicines

The Lancet Global Health
Medicine
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy